跳至主要内容
临床试验/NCT04143100
NCT04143100已完成不适用

Anxiety, Symptom Burden, and Dialysis Adherence in In-center Hemodialysis Patients

The Rogosin Institute1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2019年8月30日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
100
试验地点
1
主要终点
Generalized Anxiety Disorder-7 (GAD-7)

研究概览

简要总结

Anxiety has been identified as a prevalent and significant co-morbid condition in patients with End Stage Renal Disease (ESRD) being treated with hemodialysis. In particular, anxious sensitivity to symptoms commonly experienced by dialysis patients may lead patients to prematurely terminate their dialysis sessions and may have consequences on their dialysis adequacy and overall quality of life.

The proposed study will examine the relationships between anxiety, depression, quality of life, symptom burden and dialysis prescription adherence. The primary regression analyses will be used to predict the influence of anxiety and depression (independently and together) on measures of adherence behaviors.

详细描述

Additional analyses will examine the relationship of elevated anxiety and depression scores on symptom burden, QOL, and other measures of dialysis adherence. Retrospective data of the preceding three months will be used to calculate measures of dialysis adherence (shortening and skipping) and clinical parameters.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Receiving In-center hemodialysis

排除标准

  • Non-English speaking

结局指标

主要结局

Generalized Anxiety Disorder-7 (GAD-7)

时间窗: This is a cross-sectional study, with anxiety scores being correlated with previous 6 months of adherence data

Anxiety measure - higher scores indicate more anxiety

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Anxiety and Symptom Burden in Hemodialysis Patients | 临床试验